Jonathan Hopper - Feb 11, 2022 Form 4 Insider Report for Vericel Corp (VCEL)

Role
Chief Medical Officer
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Jonathan Hopper
Stock symbol
VCEL
Transactions as of
Feb 11, 2022
Transactions value $
-$84,624
Form type
4
Date filed
2/15/2022, 03:52 PM
Previous filing
Feb 8, 2022
Next filing
Feb 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCEL Common Stock Options Exercise $0 +1.63K +3.69% $0.00 45.7K Feb 11, 2022 Direct F1, F2
transaction VCEL Common Stock Tax liability -$27.3K -775 -1.7% $35.26 44.9K Feb 11, 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCEL Restricted Stock Unit Options Exercise -$57.3K -1.63K -33.33% $35.26 3.25K Feb 11, 2022 Common Stock 1.63K Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 11, 2020. The remaining RSUs will vest in annual installments on February 11, 2023, and February 11, 2024, respectively.
F2 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F3 These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
F4 Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
F5 No expiration date for this type of award.